Technology

AddToAny

Google+ Facebook Twitter Twitter

New breathalyser for disease

Owlstone Medical has announced the launch of its Breath Biopsy Kits.

New breathalyser for disease

 

The new product range allows academic, clinical and pharmaceutical researchers to quickly discover and validate breath-based biomarkers in early detection and precision medicine research activities.

Owlstone Medical’s Breath Biopsy platform is a new diagnostic modality capable of detecting biomarkers of disease, and also exogenous compounds, such as volatile drug metabolites, in breath.

The company’s ReCIVA Breath Sampler and new Breath Biopsy Kits ensure consistent and reliable collection of breath samples.

owlstonemedical.com

Related Articles

Tumor Markers Human Chorionic Gonadotropin Molecule Science Photo

Clinical chemistry classics: tumour markers

This short series continues with a brief review of pioneering work in the development and clinical application of two important tumour markers – serum alpha fetoprotein and urine and serum human chorionic gonadotropin.

Aldernbooke Hospital Alamy

My lab: tour of point-of-care laboratory

Michelle Lineham, Deputy Team Lead and Biomedical Scientist, gives a guided tour of her lab at Addenbrooke’s Hospital in Cambridge.

Cryobank has arrived

Mast Group is pleased to announce the arrival of the new cryobank.

New tests for analyser

Radiometer is pleased to announce the commercial launch of its CE-marked point-of-care tests for creatinine and urea.

Top